{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:45:38Z","timestamp":1790027138985,"version":"4.0.1"},"reference-count":35,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan","award":["BR21881970"],"award-info":[{"award-number":["BR21881970"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: Apolipoprotein B (ApoB), a key component of atherogenic lipoproteins, has been increasingly implicated in cardiometabolic disorders beyond dyslipidemia. However, its role in glycemic dysregulation remains unclear. This study aimed to investigate the association between ApoB levels and glycemic parameters, including fasting glucose, insulin resistance, and glycated hemoglobin (HbA1c), in individuals without diagnosed diabetes. Methods: This study was conducted at the National Research Cardiac Surgery Center (Kazakhstan) over the period between 2023 and 2024 as a cross-sectional analysis. Adults aged \u2265 20 years without diagnosed diabetes and with complete data on their ApoB and glycemic markers were included. Associations between ApoB and fasting plasma glucose (FPG), HbA1c, and HOMA-IR were assessed using multivariable linear and logistic regression models adjusted for demographic, lifestyle, and metabolic covariates. Results: Higher ApoB levels were significantly associated with increased fasting glucose (\u03b2 = 2.07 mg\/dL per 1-SD increase in ApoB, p &lt; 0.001), higher HbA1c (\u03b2 = 0.06%, p &lt; 0.001), and elevated HOMA-IR (\u03b2 = 0.54, p &lt; 0.001). Participants in the highest ApoB quartile had 53% higher odds of prediabetes (adjusted OR = 1.53; 95% CI: 1.22\u20131.91; p &lt; 0.001) compared to the lowest quartile. These associations remained significant after adjusting for BMI, lipid levels, and other confounders. Conclusions: Elevated ApoB is independently associated with adverse glycemic profiles in nondiabetic individuals, suggesting its potential role in early glucose metabolism disturbances.<\/jats:p>","DOI":"10.3390\/jpm15050163","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:38:37Z","timestamp":1745390317000},"page":"163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Apolipoprotein B and Glycemic Dysregulation: New Predictors of Type 2 Diabetes in High-Cardiovascular-Risk Populations"],"prefix":"10.3390","volume":"15","author":[{"given":"Makhabbat","family":"Bekbossynova","sequence":"first","affiliation":[{"name":"Heart Center, Corporate Fund \u201cUniversity Medical Center\u201d, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Ivanova-Razumova","sequence":"additional","affiliation":[{"name":"Heart Center, Corporate Fund \u201cUniversity Medical Center\u201d, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aknur","family":"Kali","sequence":"additional","affiliation":[{"name":"Heart Center, Corporate Fund \u201cUniversity Medical Center\u201d, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Sailybayeva","sequence":"additional","affiliation":[{"name":"Heart Center, Corporate Fund \u201cUniversity Medical Center\u201d, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6296-0507","authenticated-orcid":false,"given":"Sadyk","family":"Khamitov","sequence":"additional","affiliation":[{"name":"Heart Center, Corporate Fund \u201cUniversity Medical Center\u201d, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5876-7528","authenticated-orcid":false,"given":"Gulnur","family":"Daniyarova","sequence":"additional","affiliation":[{"name":"Heart Center, Corporate Fund \u201cUniversity Medical Center\u201d, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2527-8947","authenticated-orcid":false,"given":"Kamila","family":"Akzholova","sequence":"additional","affiliation":[{"name":"School of Medicine, Nazarbayev University, Astana 010000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-6363","authenticated-orcid":false,"given":"Timur","family":"Saliev","sequence":"additional","affiliation":[{"name":"Institute of Fundamental and Applied Medical Research, S.D. Asfendiyarov Kazakh National Medical University, Almaty 050000, Kazakhstan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.ajpc.2024.100633","article-title":"Global burden of cardiovascular diseases attributed to low physical activity: An analysis of 204 countries and territories between 1990 and 2019","volume":"17","author":"Luo","year":"2024","journal-title":"Am. J. Prevent Cardiol."},{"key":"ref_2","first-page":"100561","article-title":"Coarctation of the aorta and accelerated atherosclerosis: A contemporary review on the burden of atherosclerotic cardiovascular disease","volume":"19","author":"Lee","year":"2025","journal-title":"Int. J. Cardiol. Congen"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12944-024-02412-6","article-title":"The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes","volume":"23","author":"Gounden","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2389470","DOI":"10.1080\/07853890.2024.2389470","article-title":"Benefits of intensive lipid-lowering therapies in patients with acute coronary syndrome: A systematic review and meta-analysis","volume":"56","author":"Wu","year":"2024","journal-title":"Ann. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pcad.2024.10.009","article-title":"Revisiting high-density lipoprotein cholesterol in cardiovascular disease: Is too much of a good thing always a good thing?","volume":"87","author":"Khazzeka","year":"2024","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s12944-024-02395-4","article-title":"Dyslipidemia and metabolic syndrome in childhood-onset systemic lupus erythematosus: Is it time to screen?","volume":"23","author":"Nuntasri","year":"2024","journal-title":"Lipids Health Dis."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Benitez, S., Puig, N., Camps-Renom, P., and S\u00e1nchez-Quesada, J.L. (2024). Atherogenic circulating lipoproteins in ischemic stroke. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1470364"},{"key":"ref_8","first-page":"15","article-title":"Lipids and Inflammation: Novel Molecular Targets and Therapeutic Implications","volume":"32","author":"Triglia","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"de Oliveira, L.L.H., de Assis, A.C.R., Giraldez, V.Z.R., Scudeler, T.L., and Soares, P.R. (2024). Dyslipidemia: A Narrative Review on Pharmacotherapy. Pharmaceuticals, 17.","DOI":"10.3390\/ph17030289"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Xu, L.N., Yang, Q.Q., and Zhou, J.H. (2024). Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158465"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Zhao, M.J., Dong, Y.Z., Chen, L.C., and Shen, H.J. (2024). Influencing factors of stroke in patients with type 2 diabetes: A systematic review and meta-analysis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0305954"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/labmed\/lmae052","article-title":"Association between triglyceride to HDL cholesterol ratio and a risk of diabetes mellitus: A systematic review and meta-analysis","volume":"56","author":"Zhong","year":"2024","journal-title":"Lab. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.numecd.2018.05.010","article-title":"Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus","volume":"28","author":"Zhang","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e37415","DOI":"10.1016\/j.heliyon.2024.e37415","article-title":"Correlation between circulating lipoprotein(a) levels and cardiovascular events risk in patients with type 2 diabetes","volume":"10","author":"Gu","year":"2024","journal-title":"Heliyon"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.atherosclerosis.2022.04.016","article-title":"Lipoprotein (a) and diabetes mellitus","volume":"349","author":"Lamina","year":"2022","journal-title":"Atherosclerosis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.cjca.2024.04.017","article-title":"Dyslipidemia and the Current State of Cardiovascular Disease: Epidemiology, Risk Factors, and Effect of Lipid Lowering","volume":"40","author":"Brunham","year":"2024","journal-title":"Can. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2174\/011573403X272750240109052319","article-title":"The Role of Triglycerides in Atherosclerosis: Recent Pathophysiologic Insights and Therapeutic Implications","volume":"20","author":"Akivis","year":"2024","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.124.068885","article-title":"Apolipoprotein B: Bridging the Gap Between Evidence and Clinical Practice","volume":"150","author":"Joshi","year":"2024","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1016\/j.ihj.2023.12.001","article-title":"Apolipoprotein B\u2014An ideal biomarker for atherosclerosis?","volume":"76","author":"Singh","year":"2024","journal-title":"Indian Heart J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13075-024-03273-1","article-title":"Apolipoproteins and the risk of giant cell arteritis-a nested case-control study","volume":"26","author":"Jacobsson","year":"2024","journal-title":"Arthritis Res. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e087907","DOI":"10.1136\/bmjopen-2024-087907","article-title":"Association between sedentary time, physical activity, biochemical markers in the blood (heart and muscles) and heart failure in adults with congenital heart disease: A study protocol of a cross-sectional cohort study in Sweden (the ACHD trial protocol)","volume":"14","author":"Vahlberg","year":"2024","journal-title":"BMJ Open"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-nutr-062222-020716","article-title":"Biosynthesis and Metabolism ofApoB-Containing Lipoproteins","volume":"44","author":"Taskinen","year":"2024","journal-title":"Annu. Rev. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Moiynbayeva, S., Akhmetov, V., Narymbayeva, N., Shaikova, K., Makhanbetkulova, D., Bapayeva, M., Abdirova, T., Popova, T., and Karibayeva, I. (2024). Health policy implications for cardiovascular disease, type 2 diabetes mellitus, and stroke in Central Asia: A decadal forecast of their impact on women of reproductive age. Front. Public. Health, 12.","DOI":"10.3389\/fpubh.2024.1456187"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kulimbet, M., Davletov, K., Saliev, T., Davletov, D., Dzhumabekov, B., Umbayev, B., Balabayeva, A., Tanabayeva, S., and Fakhradiyev, I. (2024). Assessment of hypercholesterolemia prevalence and its demographic variations in the Republic of Kazakhstan. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-57884-4"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Bekbossynova, M., Aripov, M., Ivanova-Razumova, T., Kali, A., Tleubayeva, D., Daniyarova, G., and Goncharov, A. (2024). Proposing new lipoprotein (a) cut off value for Kazakhstan: Pilot study. Front. Cardiovasc. Med., 11.","DOI":"10.3389\/fcvm.2024.1468566"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/VHRM.S417693","article-title":"Recent Trends in Cardiovascular Disease Mortality in Kazakhstan","volume":"19","author":"Junusbekova","year":"2023","journal-title":"Vasc. Health Risk Man."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2147\/DDDT.S468147","article-title":"Impact of Lipids on Insulin Resistance: Insights from Human and Animal Studies","volume":"18","author":"Elkanawati","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Wang, L., Yan, N., Zhang, M., Pan, R., Dang, Y., and Niu, Y. (2022). The association between blood glucose levels and lipids or lipid ratios in type 2 diabetes patients: A cross-sectional study. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.969080"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"106117","DOI":"10.1016\/j.isci.2023.106117","article-title":"Association between cumulative lipoprotein(a) exposure and adverse cardiovascular outcomes in patients with prediabetes or diabetes","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12944-021-01504-x","article-title":"High lipoprotein(a) concentrations are associated with lower type 2 diabetes risk in the Chinese Han population: A large retrospective cohort study","volume":"20","author":"Fu","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.athplu.2024.07.001","article-title":"Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease","volume":"57","author":"Yeung","year":"2024","journal-title":"Atheroscler. Plus"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41366-024-01510-w","article-title":"Identification of circulating apolipoprotein M as a new determinant of insulin sensitivity and relationship with adiponectin","volume":"48","author":"Frances","year":"2024","journal-title":"Int. J. Obes."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.7150\/ijbs.86475","article-title":"Apolipoproteins as potential communicators play an essential role in the pathogenesis and treatment of early atherosclerosis","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1161\/ATVBAHA.123.318267","article-title":"ApoA-I and Diabetes","volume":"43","author":"King","year":"2023","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106873","DOI":"10.1016\/j.phrs.2023.106873","article-title":"Apolipoprotein B compared with low-density lipoprotein cholesterol in the atherosclerotic cardiovascular diseases risk assessment","volume":"195","author":"Galimberti","year":"2023","journal-title":"Pharmacol. Res."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/5\/163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:58Z","timestamp":1760030398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/5\/163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jpm15050163"],"URL":"https:\/\/doi.org\/10.3390\/jpm15050163","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]}}}